Wellgistics Health Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $14M-85.6% YoYTTM through 31 Mar 2026
Net Income -$76.6MTTM through 31 Mar 2026
Free Cash Flow -$10.9MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Gross Margin | 10.9% |
| Operating Margin | -496.5% |
| Net Margin | -496.5% |
Returns
51.4%ROE
-79.2%ROA
Balance Sheet Health
Debt / Equity-1.84x
Net Debt$23.4M
Cash & Equivalents$51.7K
Quality Metrics
FCF Margin-77.4%
Dividend
No dividend
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Wellgistics Pharmacy | View detailsExpected to drive sequential growth and integrate licensed PharmacyChain data tokenization technology into the EinsteinRx AI platform. | ||
| Distribution | View detailsTransitioning toward a direct-to-consumer pharmacy and health-tech model to reduce reliance on traditional wholesale distribution. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.